BCM
CMRA

Bluefin Capital Management’s Comera Life Sciences Holdings, Inc. Common Stock CMRA Stock Holding History

Bluefin Capital Management’s Portfolio CMRA Stock Details CMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-19,584
Closed -$32K – 689
2022
Q3 		$32K Sell
19,584
-7,927
-29% -$19K ﹤0.01% 411
2022
Q2 		$73K Buy
+27,511
New +$91.1K 0.01% 382

Other funds holding CMRA

LSAG
Lake Street Advisors Group Portsmouth, New Hampshire $2.17B AUM 16.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HighTower Advisors
HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

Bluefin Capital Management's CMRA Position: Q4 2022 in Review

Bluefin Capital Management sold out of Comera Life Sciences Holdings, Inc. Common Stock (CMRA) in Q4 2022, closing a stake of 19,584 shares — an estimated $32K sold.

Bluefin Capital Management first reported a position in CMRA in Q2 2022 and held it in 2 quarters. The position peaked at $73K in Q2 2022. 12 funds tracked by Wall St. Rank hold CMRA as of Q4 2022.

  • Bluefin Capital Management reported no remaining Comera Life Sciences Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Bluefin Capital Management sold 19,584 Comera Life Sciences Holdings, Inc. Common Stock shares in Q4 2022, an estimated $32K.
  • Bluefin Capital Management first reported a position in Comera Life Sciences Holdings, Inc. Common Stock in Q2 2022 and held it in 2 quarters.
  • Bluefin Capital Management's Comera Life Sciences Holdings, Inc. Common Stock position peaked at $73K in Q2 2022.
  • 12 funds tracked by Wall St. Rank held Comera Life Sciences Holdings, Inc. Common Stock as of Q4 2022.

Based on Bluefin Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.